Related Experiment Video
Updated: Oct 8, 2026
In Vitro Evaluation of Oncogenic Transformation in Human Mammary Epithelial Cells
Published on: September 24, 2020
In vitro activity of a Solanum tuberosum extract against mammary carcinoma cells
Abstract:
We investigated the antitumor properties of a Solanum tuberosum extract (STE) on F3II mouse mammary carcinoma cells. STE significantly inhibited adhesion on fibronectin-coated surfaces and blocked migration of tumor cells in vitro. A major gelatinolytic activity (gelatinase) of 82 kD was identified in STE by zymographic analysis and characterized by exposure to different experimental conditions. Proteolytic activity of STE may be responsible, at least in part, for the in vitro effects on mammary carcinoma cells.
Insights
Solanum tuberosum extract (STE) demonstrated antitumor effects by inhibiting F3II mouse mammary carcinoma cell adhesion and migration in vitro. This activity is potentially linked to a significant 82 kD gelatinase identified within the extract.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Investigating natural compounds for cancer therapy is crucial.
- Solanum tuberosum (potato) extracts are explored for bioactive properties.
Discussion:
- The Solanum tuberosum extract (STE) exhibited significant inhibition of F3II mouse mammary carcinoma cell adhesion to fibronectin.
- STE effectively blocked tumor cell migration in in vitro assays.
- An 82 kD gelatinase was identified as a major component of STE via zymography.
Key Insights:
- STE possesses antitumor properties against mammary carcinoma cells.
- The extract's ability to inhibit cell adhesion and migration is a key finding.
- Proteolytic activity, specifically gelatinase, is implicated in STE's observed effects.
Outlook:
- Further characterization of the 82 kD gelatinase could reveal therapeutic potential.
- In vivo studies are warranted to confirm STE's efficacy and safety.
- Exploring other Solanum tuberosum varieties may yield novel antitumor agents.
